Breadcrumb Home Media Press Releases media Press Releases Subscribe to our press releases 2025 01/04/2025 Availability of the 2024 Universal Registration Document, including the Annual Financial Report Download the pdf version 03/03/2025 Full-Year 2024 Results Download the pdf version 06/01/2025 EUROAPI welcomes the French Minister for Health and Access to Healthcare Yannick Neuder and the French Minister for Industry and Energy Marc Ferracci to its Puy-de-Dôme site Download the pdf version 2024 24/12/2024 Information relating to the financial terms of the departure of the Chairman and the Chief Executive Officer and the appointment of the new Chairman of the Board and the new Chief Executive Officer Download the pdf version 09/12/2024 EUROAPI moves into a new chapter with new Governance and Leadership Download the pdf version 16/10/2024 Olivier Falut appointed EUROAPI’s Chief Financial Officer Download the pdf version 15/10/2024 EUROAPI closes the financing of its FOCUS-27 plan Download the pdf version 10/10/2024 EUROAPI completes the financing of its FOCUS-27 plan and moves forward with its execution Download the pdf version 05/08/2024 Availability of H1-24 Financial Report Download the pdf version 30/07/2024 H1 2024 Results Download the pdf version 26/06/2024 EUROAPI is moving ahead with its FOCUS-27 plan, setting the foundations for future profitable growth Download the pdf version 18/06/2024 EUROAPI and Priothera enter into CDMO collaboration to advance oncology project Download the pdf version 06/06/2024 Market update - FOCUS-27 transformation project financing Download the pdf version 06/06/2024 EUROAPI reaches major Health IPCEI milestone with official notification from European Commission Download the pdf version 23/05/2024 EUROAPI strengthens its presence in animal health with a €130-150 million supply contract Download the pdf version 22/05/2024 Combined General Meeting of May 22, 2024 Download the pdf version 13/05/2024 Evelyne Nguyen appointed EUROAPI’s Chief Financial Officer Download the pdf version 30/04/2024 Combined General Meeting of May 22, 2024 - Availability of preparatory documents Download the pdf version 09/04/2024 EUROAPI streamlines its Executive Committee to improve focus and efficiency Download the pdf version 05/04/2024 05-APRIL-2024 – EUROAPI Availability of the 2023 Universal Registration Document, including the Annual Financial Report Download the pdf version 14/03/2024 Full-year 2024 guidance suspended due to the temporary pause of API production at the Brindisi site in Italy Download the pdf version 28/02/2024 Full-Year 2023 results Download the pdf version 25/01/2024 EUROAPI enhances its CDMO capabilities through a pivotal collaboration with SpiroChem, a leading Contract Research Organization (CRO) Download the pdf version 04/01/2024 EUROAPI strengthens its Executive Committee with the appointment of Ludwig de Mot as Executive Vice President - Chief Transformation Officer Download the pdf version 2023 28/11/2023 EUROAPI appoints new Executive Committee members Download the pdf version 21/11/2023 CDMO: EUROAPI completes acquisition of Biano Download the pdf version 30/10/2023 Information relating to the financial terms of the departure of the Chief Executive Officer Download the pdf version 25/10/2023 EUROAPI announces new governance Download the pdf version 24/10/2023 EUROAPI increases the resources allocated to the liquidity contract with Kepler Cheuvreux Download the pdf version 09/10/2023 Full-Year 2023 outlook revised downwards Launch of a strategic review Mid-term perspectives suspended Download the pdf version 29/08/2023 EUROAPI to acquire BianoGMP to strengthen its CDMO expertise in the high-growth oligonucleotide market Download the pdf version 02/08/2023 Availability of H1-23 Financial Report_02AUG23 Download the pdf version 01/08/2023 EUROAPI H1 2023 Results Download the pdf version 13/06/2023 Health sovereignty: EUROAPI supports the supply of essential medicines to France and Europe Download the pdf version 25/10/2023 EUROAPI announces new governance Download the pdf version 06/06/2023 EUROAPI to invest €50 million at its Budapest site to meet the growing demand for prostaglandins Download the pdf version 11/05/2023 Combined General Meeting of May 11, 2023 Download the pdf version 10/05/2023 EUROAPI’s Board of Directors proposes Géraldine Leveau as Director Download the pdf version 09/05/2023 EUROAPI and Novéal sign CDMO agreement to advance cosmetic projects Download the pdf version 26/04/2023 Availability of the Amendment n°1 of the 2022 Universal Registration Document Download the pdf version 14/04/2023 Availability of the 2022 Universal Registration Document, including the Annual Financial Report Download the pdf version 08/03/2023 EUROAPI Full-Year 2022 Results_March 8 2023 Download the pdf version 31/01/2023 Progressive restart of prostaglandin production at Budapest site Download the pdf version 11/01/2023 EUROAPI’s Board of Directors proposes Mattias Perjos as independent Director Download the pdf version 09/01/2023 Vitamin B12: EUROAPI to invest €40 million for a more efficient and sustainable production process in France Download the pdf version 2022 07/12/2022 EUROAPI updates its 2022 financial guidance Download the pdf version 31/10/2022 EUROAPI to reach 500 kg peptide and oligonucleotide capacity per year in Frankfurt by 2025 Download the pdf version 01/09/2022 Availability of 2022 Half-Year Financial Report Download the pdf version 01/09/2022 EUROAPI 2022 Half-year results Download the pdf version 22/07/2022 EUROAPI announces the success of its first global employee share plan “EUROAPI Action 2022” Download the pdf version 21/07/2022 ESG: EUROAPI moves forward with its carbon reduction ambition and invests to build a state-of-the-art biomass boiler in France Download the pdf version 01/07/2022 Availability of EUROAPI’s 2021 half-year results Download the pdf version 09/06/2022 EUROAPI joins the SBF 120 and CAC Mid 60 indices Download the pdf version 03/06/2022 EUROAPI launches its first global employee share plan “EUROAPI Action 2022” Download the pdf version 01/06/2022 EUROAPI implements a liquidity contract with Kepler Cheuvreux Download the pdf version 30/05/2022 CDMO: EUROAPI supports Sanofi’s mRNA vaccine platform with the development of lipid nanoparticles Download the pdf version 06/05/2022 EUROAPI announces the success of its listing on Euronext Paris Download the pdf version 03/05/2022 EUROAPI announces that all conditions required for its upcoming listing on Euronext Paris have now been successfully met Download the pdf version 01/04/2022 EUROAPI announces the French AMF approval on its prospectus and moves towards its listing on Euronext Paris expected on May 6, 2022 Download the pdf version
01/04/2025 Availability of the 2024 Universal Registration Document, including the Annual Financial Report Download the pdf version
06/01/2025 EUROAPI welcomes the French Minister for Health and Access to Healthcare Yannick Neuder and the French Minister for Industry and Energy Marc Ferracci to its Puy-de-Dôme site Download the pdf version
24/12/2024 Information relating to the financial terms of the departure of the Chairman and the Chief Executive Officer and the appointment of the new Chairman of the Board and the new Chief Executive Officer Download the pdf version
09/12/2024 EUROAPI moves into a new chapter with new Governance and Leadership Download the pdf version
10/10/2024 EUROAPI completes the financing of its FOCUS-27 plan and moves forward with its execution Download the pdf version
26/06/2024 EUROAPI is moving ahead with its FOCUS-27 plan, setting the foundations for future profitable growth Download the pdf version
18/06/2024 EUROAPI and Priothera enter into CDMO collaboration to advance oncology project Download the pdf version
06/06/2024 EUROAPI reaches major Health IPCEI milestone with official notification from European Commission Download the pdf version
23/05/2024 EUROAPI strengthens its presence in animal health with a €130-150 million supply contract Download the pdf version
30/04/2024 Combined General Meeting of May 22, 2024 - Availability of preparatory documents Download the pdf version
09/04/2024 EUROAPI streamlines its Executive Committee to improve focus and efficiency Download the pdf version
05/04/2024 05-APRIL-2024 – EUROAPI Availability of the 2023 Universal Registration Document, including the Annual Financial Report Download the pdf version
14/03/2024 Full-year 2024 guidance suspended due to the temporary pause of API production at the Brindisi site in Italy Download the pdf version
25/01/2024 EUROAPI enhances its CDMO capabilities through a pivotal collaboration with SpiroChem, a leading Contract Research Organization (CRO) Download the pdf version
04/01/2024 EUROAPI strengthens its Executive Committee with the appointment of Ludwig de Mot as Executive Vice President - Chief Transformation Officer Download the pdf version
30/10/2023 Information relating to the financial terms of the departure of the Chief Executive Officer Download the pdf version
24/10/2023 EUROAPI increases the resources allocated to the liquidity contract with Kepler Cheuvreux Download the pdf version
09/10/2023 Full-Year 2023 outlook revised downwards Launch of a strategic review Mid-term perspectives suspended Download the pdf version
29/08/2023 EUROAPI to acquire BianoGMP to strengthen its CDMO expertise in the high-growth oligonucleotide market Download the pdf version
13/06/2023 Health sovereignty: EUROAPI supports the supply of essential medicines to France and Europe Download the pdf version
06/06/2023 EUROAPI to invest €50 million at its Budapest site to meet the growing demand for prostaglandins Download the pdf version
10/05/2023 EUROAPI’s Board of Directors proposes Géraldine Leveau as Director Download the pdf version
09/05/2023 EUROAPI and Novéal sign CDMO agreement to advance cosmetic projects Download the pdf version
26/04/2023 Availability of the Amendment n°1 of the 2022 Universal Registration Document Download the pdf version
14/04/2023 Availability of the 2022 Universal Registration Document, including the Annual Financial Report Download the pdf version
11/01/2023 EUROAPI’s Board of Directors proposes Mattias Perjos as independent Director Download the pdf version
09/01/2023 Vitamin B12: EUROAPI to invest €40 million for a more efficient and sustainable production process in France Download the pdf version
31/10/2022 EUROAPI to reach 500 kg peptide and oligonucleotide capacity per year in Frankfurt by 2025 Download the pdf version
22/07/2022 EUROAPI announces the success of its first global employee share plan “EUROAPI Action 2022” Download the pdf version
21/07/2022 ESG: EUROAPI moves forward with its carbon reduction ambition and invests to build a state-of-the-art biomass boiler in France Download the pdf version
03/06/2022 EUROAPI launches its first global employee share plan “EUROAPI Action 2022” Download the pdf version
30/05/2022 CDMO: EUROAPI supports Sanofi’s mRNA vaccine platform with the development of lipid nanoparticles Download the pdf version
03/05/2022 EUROAPI announces that all conditions required for its upcoming listing on Euronext Paris have now been successfully met Download the pdf version
01/04/2022 EUROAPI announces the French AMF approval on its prospectus and moves towards its listing on Euronext Paris expected on May 6, 2022 Download the pdf version